Introducing ethics in hospital drug resource allocation decisions: keep expectations modest and beware of unintended effects Part I: An explorative overview
2002; Wiley; Volume: 11; Issue: 6 Linguagem: Inglês
10.1002/pds.751
ISSN1099-1557
AutoresR. Fijn, L. Sara van Epenhuysen, A.J.M. Peijnenburg, Lolkje T.W. de Jong‐van den Berg, J. R. B. J. Brouwers,
Tópico(s)Health Systems, Economic Evaluations, Quality of Life
ResumoPharmacoepidemiology and Drug SafetyVolume 11, Issue 6 p. 523-527 ISPE Commentary Introducing ethics in hospital drug resource allocation decisions: keep expectations modest and beware of unintended effects Part I: An explorative overview Roel Fijn PhD, MS, MA, RPh, RCE, Corresponding Author Roel Fijn PhD, MS, MA, RPh, RCE [email protected] Division of Pharmacoepidemiology and Drug Policy, Groningen University Institute for Drug Exploration (GUIDE), Department of Social Pharmacy, Pharmacoepidemiology, and Pharmacotherapy, University of Groningen, The NetherlandsMedical Sciences and Pharmacy, Department of Social Pharmacy and Pharmacoepidemiology, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands.Search for more papers by this authorL. Sara van Epenhuysen MA, L. Sara van Epenhuysen MA Department of Metamedica (Philosophy, Ethics, and History of Medicine), Medical Sciences and Pharmacy, University of Groningen and Medical Ethics Committee, Groningen University Hospital, Groningen, The NetherlandsSearch for more papers by this authorA. Jeanne M. Peijnenburg PhD, MA, A. Jeanne M. Peijnenburg PhD, MA Department of Theoretical Philosophy (Philosophy of Science, Logic and Epistemology), Philosophical Institute, University of Groningen, Groningen, The NetherlandsSearch for more papers by this authorLolkje T. W. de Jong-van den Berg PhD, MS, RPh, RCE, Lolkje T. W. de Jong-van den Berg PhD, MS, RPh, RCE Division of Pharmacoepidemiology and Drug Policy, Groningen University Institute for Drug Exploration (GUIDE), Department of Social Pharmacy, Pharmacoepidemiology, and Pharmacotherapy, University of Groningen, The NetherlandsSearch for more papers by this authorJacobus R. B. J. Brouwers PhD, MS, RPh, RCP, Jacobus R. B. J. Brouwers PhD, MS, RPh, RCP Departments of Clinical Pharmacology and Hospital Pharmacy, Leeuwarden Medical Centre, Leeuwarden and General Hospital de Tjongerschans Heerenveen, The NetherlandsSearch for more papers by this author Roel Fijn PhD, MS, MA, RPh, RCE, Corresponding Author Roel Fijn PhD, MS, MA, RPh, RCE [email protected] Division of Pharmacoepidemiology and Drug Policy, Groningen University Institute for Drug Exploration (GUIDE), Department of Social Pharmacy, Pharmacoepidemiology, and Pharmacotherapy, University of Groningen, The NetherlandsMedical Sciences and Pharmacy, Department of Social Pharmacy and Pharmacoepidemiology, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands.Search for more papers by this authorL. Sara van Epenhuysen MA, L. Sara van Epenhuysen MA Department of Metamedica (Philosophy, Ethics, and History of Medicine), Medical Sciences and Pharmacy, University of Groningen and Medical Ethics Committee, Groningen University Hospital, Groningen, The NetherlandsSearch for more papers by this authorA. Jeanne M. Peijnenburg PhD, MA, A. Jeanne M. Peijnenburg PhD, MA Department of Theoretical Philosophy (Philosophy of Science, Logic and Epistemology), Philosophical Institute, University of Groningen, Groningen, The NetherlandsSearch for more papers by this authorLolkje T. W. de Jong-van den Berg PhD, MS, RPh, RCE, Lolkje T. W. de Jong-van den Berg PhD, MS, RPh, RCE Division of Pharmacoepidemiology and Drug Policy, Groningen University Institute for Drug Exploration (GUIDE), Department of Social Pharmacy, Pharmacoepidemiology, and Pharmacotherapy, University of Groningen, The NetherlandsSearch for more papers by this authorJacobus R. B. J. Brouwers PhD, MS, RPh, RCP, Jacobus R. B. J. Brouwers PhD, MS, RPh, RCP Departments of Clinical Pharmacology and Hospital Pharmacy, Leeuwarden Medical Centre, Leeuwarden and General Hospital de Tjongerschans Heerenveen, The NetherlandsSearch for more papers by this author First published: 26 September 2002 https://doi.org/10.1002/pds.751Citations: 2AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Fijn R, van Epenhuysen LS, Peijnenburg AJM, Brouwers JRBJ, de Jong-van den Berg LTW. Is there a need for critical ethical and philosophical evaluation of hospital drugs and therapeutics (D&T) committees? Pharmacoepidemiol Drug Safe 2002; 11: 247–252. 2 Furnham A. Factors relating to the allocation of medical resources. J Soc Behav Personal 1996; 11(3): 615–624. 3 Loewy EH. Problems of macro allocation. Textbook of Health Care Ethics. Plenum Press: New York, USA, 1996; 239–266. 4 Elster J. The ethics of medical choice. The Ethics of Medical Choice, J Elster, N Herpin (eds). London: Actes Sud, 1994; 1–22. 5 Munson R. Competition and allocation. Intervention and Reflection. Basic Issues in Medical Ethics, K King (ed.). Wadsworth Inc.: Belmont California, USA, 1983; 483–516. 6 Towsley–Cook DM, Young TA. Health Care Distribution. Ethical and Legal Issues. Mosby Inc.: St Louis Missouri, USA, 1999; 127–148. 7 Cherry C. Health care, human worth and the limits of the particular. J Med Ethics 1997; 23(5): 310–314. 8 Emanuel EJ. Justice and managed care. Hastings Center Report 2000; 30(3): 8–16. 9 Callahan D. What kind of life? The Limits of Medical Progress ( 2 edn). Georgetown University Press: Washington, USA, 1996. 10 Crisp R, Hope T. The Ashbury Draft Policy on Ethical Use of Resources. BMJ 1996; 312(7045): 1528–1531. 11 Bochner F, Burgess NG, Dean Martin E. Approaches to rationing drugs in hospitals. An Australian perspective. Pharmacoeconomics 1996; 10(5): 467–474. 12 Rucker TD, Schiff G. Drug formularies: myths-in-formation. Med Care 1990; 28(10): 928–4219. 13 Audet AM, Greenfield S, Field M. Medical practice guidelines: current activities and future directions. Ann Intern Med 1990; 113: 709–714. 14 Thomson A. Moral principles and moral theories. In Critical Reasoning in Ethics. Routledge: London, 1999; 123–141. 15 Towsley–Cook DM, Young TA. Ethical and legal foundations. In Ethical and Legal Issues. Mosby Inc.: St Louis Missouri, USA, 1999; 1–26. 16 Gilley J. Towards rational prescribing. Better prescribing takes time. BMJ 1994; 308(3): 731–732. 17 Jonsen A, Haddad A, Helling KK, McAllister JC, III. Fortresses and formularies: drugs, ethics, and managed care. Am J Health Syst Pharm 2000; 57(9): 853–860. 18 Towsley–Cook DM, Young TA. Principles of beneficence and nonmaleficence. Ethical and Legal Issues. Mosby Inc.: St Louis Missouri, USA, 1999; 27–50. 19 Towsley–Cook DM, Young TA. Patient autonomy and informed consent. Ethical and legal issues. Mosby Inc.: St Louis Missouri, USA, 1999; 51–74. 20 Boyd KM. Health care ethics, health and disease. Principles of Health Care Ethics, R Gillon, A Lloyd (eds). John Wiley & Sons Ltd: Chichester, UK, 1994; 807–818. 21 Lisi DM. Ethical issues for pharmacists in managed care. Am J Health Syst Pharm 1997; 54(9): 1041–1045. 22 Prayle D, Brazier M. Supply of medicines: paternalism, autonomy and reality. J Med Ethics 1998; 24(2): 93–98. 23 Sommerville A, Fischer F, Macdonald N, Lloyd A. Rationing and Allocation of Health Care Resources. Medical Ethics Today. British Medical Journal Publishing Group: London, 1993: 299–324. 24 Williams A. Economics, society and health care ethics. In Principles of Health Care Ethics, R Gillon, A Lloyd (eds). John Wiley & Sons Ltd: Chichester, UK, 1994; 829–842. Citing Literature Volume11, Issue6September 2002Pages 523-527 ReferencesRelatedInformation
Referência(s)